2022 E/M Clarifications Continue

Why This Topic Matters

Accurate understanding of E/M documentation and data review concepts affects office visit leveling, auditing, and physician education. The article helps readers interpret AMA clarification in a way that supports more consistent application of the 2021 guidelines.

Article Sections

1. Introduction and symposium context

   Introduces the 2022 CPT Symposium and the purpose of the session on E/M clarification. It also identifies the presenters and the general focus of the article.

2. Tests: What Can Be Counted?

   Discusses clarification related to how certain tests are treated in the data component of medical decision-making. The section addresses questions raised about ordered tests and related review concepts.

3. Tests: What Does Analyzed Mean?

   Explains the AMA's clarification of how the term analyzed is being used in the E/M guidance. It covers how this concept relates to recurring testing and counting data across encounters.

4. Tests: What Is the Meaning of "Unique" and "Independent Interpretation"?

   Reviews clarification on what qualifies as a unique test and how independent interpretation is being discussed in the E/M framework. It also covers related questions about repeated results and source grouping.

5. Tests: Combination of Data Elements?

   Summarizes guidance on combining different data elements within the E/M data table. The section also addresses how documentation of consideration, ordering, and review is discussed in relation to visit leveling.

6. Discussion Between Physicians and OQHCPs

   Covers clarification on what qualifies as discussion between clinicians for E/M purposes. It emphasizes the communication format and timing considerations discussed in the article.